Abstract
The COVID-19 infection rapidly spread globally, mostly affecting the extremely vulnerable category of the elderly with comorbidities. There are inconsistencies in the findings on the type of comorbidity of the elderly and its association with fatalities. In this context, this research investigated the impact of comorbidity in the fatality of elderly COVID-19 patients in Kerala based on their healthcare status, functionality, and morbidity profiles. A concurrent mixed-method approach was adopted for the study to achieve the objectives, where the quantitative and qualitative data had been collected in the COVID-19 situation, from June to November 2020. This study’s findings have been further triangulated with the COVID-19 elderly fatality data, which is available from the crowdsourced dashboard of the research team and two other volunteering dashboards. This paper establishes that comorbidities can predict potential fatality among elderly COVID-19 patients. While facing an epidemic like the present zoonotic disease, better knowledge of these high-risk factors will help clinicians to pinpoint the situation and implement therapeutic and preventive methodologies and interventions. The comorbidity level of the elderly in Kerala matches with the profile of COVID-19 death cases where heart disease, diabetes, cancer, and hypertension are the significant predictors of COVID-19 elderly fatality in Kerala.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
The first author acknowledges financial support from the Indian Council for Social Science Research under the IMPRESS grant (F.No. IMPRESS/P1132/428/2018-19/ICSSR).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The entire study was conducted following the guidelines and ethical approval received from the Indian Council for Social Science Research (F.No. IMPRESS/P1132/428/2018-19/ICSSR). Informed consent was obtained from the respondents before collecting their data.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Paper in collection COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv
The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, University of Washington, and Vrije Universiteit Amsterdam.
Subject Area
Reviews and Context
0
Comment
0
TRIP Peer Reviews
0
Community Reviews
0
Automated Services
0
Blogs/Media
Author Videos